Literature DB >> 9324289

Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells.

F Leteurtre1, X Li, E Gluckman, E D Carosella.   

Abstract

Telomeric DNA protects chromosome ends from recombination events and its length serves as a mitotic clock that triggers exit from the cell cycle when telomeres become too short. Telomerase is the enzyme involved in telomere elongation, one of the events that permits unlimited cell proliferation. Variations in telomerase activity were quantified in hematopoietic cell lines after gamma-irradiation. Telomerase activity increased after irradiation of between 0 and 3 Gy in a dose-dependent manner, reaching a maximum at 3 Gy. The increase in telomerase activity was nearly maximum 8 h after irradiation, the peak being observed at around 24 h. Although this kinetics partly correlated with cell redistribution into the G2/M phase of the cell cycle, telomerase activity did not show significant variation over the cell cycle. Therefore, the activation of telomerase observed after gamma-irradiation may suggest the involvement of telomerase in DNA repair and chromosome healing.

Mesh:

Substances:

Year:  1997        PMID: 9324289     DOI: 10.1038/sj.leu.2400784

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

Review 2.  Telomere biology: integrating chromosomal end protection with DNA damage response.

Authors:  Predrag Slijepcevic; Suliman Al-Wahiby
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

3.  Changes in telomere length distribution in low-dose X-ray-irradiated human umbilical vein endothelial cells.

Authors:  Jing-Zhi Guan; Wei Ping Guan; Toyoki Maeda; Naoki Makino
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

Review 4.  Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Authors:  Deepa M Sridharan; Aroumougame Asaithamby; Steve R Blattnig; Sylvain V Costes; Paul W Doetsch; William S Dynan; Philip Hahnfeldt; Lynn Hlatky; Yared Kidane; Amy Kronenberg; Mamta D Naidu; Leif E Peterson; Ianik Plante; Artem L Ponomarev; Janapriya Saha; Antoine M Snijders; Kalayarasan Srinivasan; Jonathan Tang; Erica Werner; Janice M Pluth
Journal:  Life Sci Space Res (Amst)       Date:  2016-05-21

Review 5.  Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.

Authors:  Grace Shim; Michelle Ricoul; William M Hempel; Edouard I Azzam; Laure Sabatier
Journal:  Mutat Res Rev Mutat Res       Date:  2014-01-31       Impact factor: 5.657

Review 6.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

7.  Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.

Authors:  Dao-Yong Liu; Zhi-Hai Peng; Guo-Qiang Qiu; Chong-Zhi Zhou
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.

Authors:  Wenbo Wang; Lei Yang; Liu Hu; Fen Li; Li Ren; Haijun Yu; Yu Liu; Ling Xia; Han Lei; Zhengkai Liao; Fuxiang Zhou; Conghua Xie; Yunfeng Zhou
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population.

Authors:  Xianli He; Qing Qiao; Naijian Ge; Jing Nan; Shuqun Shen; Zizhong Wang; Yefa Yang; Guoqiang Bao
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

10.  Telomere profiling: toward glioblastoma personalized medicine.

Authors:  Sylvain Ferrandon; Paul Saultier; Julien Carras; Priscillia Battiston-Montagne; Gersende Alphonse; Michael Beuve; Céline Malleval; Jérôme Honnorat; Tania Slatter; Noelyn Hung; Janice Royds; Claire Rodriguez-Lafrasse; Delphine Poncet
Journal:  Mol Neurobiol       Date:  2012-10-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.